Boston Scientific
479 hedge funds and large institutions have $22.2B invested in Boston Scientific in 2015 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 159 increasing their positions, 168 reducing their positions, and 35 closing their positions.
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
37% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 35
2.25% more ownership
Funds ownership: 90.71% → 92.95% (+2.2%)
2% more funds holding
Funds holding: 469 → 479 (+10)
3% more capital invested
Capital invested by funds: $21.5B → $22.2B (+$713M)
5% less repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 168
6% less call options, than puts
Call options by funds: $21.3M | Put options by funds: $22.7M
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$293M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$84.6M |
| 3 |
Renaissance Technologies
New York
|
-$50.4M |
| 4 |
Goldman Sachs
New York
|
-$50.2M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$49.8M |
BSX Hedge Fund Activity: Q3 2015 in Review
479 of the 3,581 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2015, worth a combined $22.2B — up 3.3% from $21.5B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new BSX positions and 35 closed out — a net gain of 13 holders — while 159 added to existing stakes and 168 trimmed.
The largest buyer was Janus Henderson Investors US, adding an estimated $240M. The largest seller was JP Morgan Chase, cutting an estimated $293M.
- 479 institutional investors held Boston Scientific (BSX) as of Q3 2015, up from 469 in Q2 2015.
- Funds reported $22.2B of Boston Scientific stock for Q3 2015, up 3.3% quarter-over-quarter.
- 48 funds opened new Boston Scientific positions in Q3 2015 and 35 closed out, a net change of +13 holders.
- The largest Boston Scientific buyer in Q3 2015 was Janus Henderson Investors US, an estimated $240M added.
- The largest Boston Scientific seller in Q3 2015 was JP Morgan Chase, an estimated $293M sold.
Based on aggregated 13F filings for Q3 2015.